# Fibrinogen to Albumin Ratio (FAR) as a Predictive Biomarker for Lupus Nephritis (LN)

> **NCT06288308** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 90 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DIAGNOSTIC_TEST:** fibronigin to albumin ratio

## Key facts

- **NCT ID:** NCT06288308
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-20
- **Primary completion:** 2024-11
- **Final completion:** 2024-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06288308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06288308, "Fibrinogen to Albumin Ratio (FAR) as a Predictive Biomarker for Lupus Nephritis (LN)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06288308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*